DEVELOPMENT AND EVALUATION OF ANTIDIABETIC POLYHERBAL TABLET USING MEDICINAL PLANTS OF TRADITIONAL USE
DOI:
https://doi.org/10.22159/ijcpr.2023v15i2.2095Keywords:
Medicinal plants, Adenanthera pavonina, Kigelia africana, Parkia biglandulosa, Syzygium jambose, Polyherbal tabletAbstract
Objective: The aim of the present study is to develop and evaluate poly herbal tablet prepared for management of diabetes with enhanced disintegration time.
Methods: The polyherbal extract prepared using methanolic extract of selected traditionally used medicinal plants such as Adenanthera pavonina, Kigelia africana, Parkia biglandulosa and Syzygium jambose (1:1:1:2) was evaluated in the alloxan monohydrate induced diabetic rat model. The polyherbal tablets were prepared by wet granulation method with excipients microcrystalline cellulose, dicalcium phosphate dehydrate and sodium starch glycolate. After preformulation studies tablets were evaluated by using weight variation, hardness, friability and disintegration time. The diabetic rats treated with polyherbal extract were compared with the diabetic control rats group.
Results: Positive results were obtained in the observed parameters, thus favoring the use of the plants. Pre-formulation study revealed that all the evaluated parameters were found to be within the acceptable limits. The weight variation of the formulated tablets was 1.43 % RSD. The disintegration time of the formulations was found to be 9.50 minutes. The tablets also underwent accelerated stability over the period of three months. No marked changes were observed in all the parameters evaluated during three months of accelerated stability study.
Conclusion: Laboratory-scale preparation of polyherbal tablet can lead to new powerful and stable oral dosage formulations for diabetes mellitus and lighten the synergistic area of action of herbs.
Downloads
References
Chandra H, Bishnoi P, Yadav A, Patni B, Mishra AP, Nautiyal AR. Antimicrobial resistance and the alternative resources with special emphasis on plant-based antimicrobials-a review. Plants (Basel). 2017;6(2):16. doi: 10.3390/ plants6020016, PMID 28394295.
Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature. 2016;529(7586):336-43. doi: 10.1038/nature17042, PMID 26791724.
Chin YW, Balunas MJ, Chai HB, Kinghorn AD. Drug discovery from natural sources. AAPS J. 2006;8(2):E239-53. doi: 10.1007/BF02854894, PMID 16796374.
Sheikh Y, Maibam BC, Biswas D, Laisharm S, Deb L, Talukdar NC. Anti-diabetic potential of selected ethnomedicinal plants of north East India. J Ethnopharmacol. 2015;171:37-41. doi: 10.1016/j.jep.2015.05.030, PMID 26023028.
Atanasov AG, Zotchev SB, Dirsch VM, International natural product sciences taskforce, supuran ct. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200-16. doi: 10.1038/s41573-020-00114-z, PMID 33510482.
Tran N, Pham B, Le L. Bioactive compounds in anti-diabetic plants: from herbal medicine to modern drug discovery. Biology. 2020;9(9):252. doi: 10.3390/biology9090252, PMID 32872226.
Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 2002;81(1):81-100. doi: 10.1016/s0378-8741(02)00059-4, PMID 12020931.
Rizvi SI, Mishra N. Traditional Indian medicines used for the management of diabetes mellitus. J Diabetes Res. 2013. doi: 10.1155/2013/712092, PMID 23841105.
Roy A, Gupta PP, Bharadwaj S, Chandrakar S. Antidiabetic activity of polyherbal formulations from Chhattisgarh State. Res J Pharm Technol. 2021;14(3):1375-9. doi: 10.5958/0974-360X.2021.00245.6.
Rafe MR. A review of five traditionally used anti-diabetic plants of Bangladesh and their pharmacological activities. Asian Pac J Trop Med. 2017;10(10):933-9. doi: 10.1016/j.apjtm.2017.09.002. PMID 29111187.
Rohini CK, Rajesh YC. Ethnopharmacology, phytochemistry and pharmacology of Adenanthera pavonina L. (Mimosaceae). Res J Pharmacol Pharmacodyn. 2019;11(4):140-6. doi: 10.5958/2321-5836.2019.00025.9.
Nigam SK, Misra G, Mitra CR. Stigmasterol glucoside a constituent of Adenanthera pavonina seed and leaf. Planta Med. 1973;23(2):145-8. doi: 10.1055/s-0028-1099425, PMID 4705793.
Hussain HH, Sarfaraj M. Pharmacognostical standardization of stem bark of adenanthera pavonina L. Phcog Net. 2010;2(8):1-8.
Kolhe RC, Chaudhari RY. Comprehension of phytochemical and pharmacological study of Kigelia africana (Bignoniaceae). Int J Pharmacogn Life Sci. 2020;1(1):27-32. doi: 10.33545/27072827.2020.
Lazare SS, Raduis M, Valerie ML, Gaetan H, Tchinda AT, Ollivier E. Triterpenes and lignans from Kigelia african. J Appl Pharm Sci. 2015;5(2):1-6.
Ramakrishna E, Dev K, Kothari P, Tripathi AK, Trivedi R, Maurya R. Phytochemical investigation of Kigelia pinnata leaves and identification of osteogenic agents. Med Chem Res. 2017;26(5):940-6. doi: 10.1007/s00044-017-1807-z.
Rohini CK, Rajesh YC. A review on phytopharmacological profile of traditionally used medicinal plant parkia biglandulosa (Mimosaceae). Asian Jour Pharmac Rese 2020;10(1). doi: 10.5958/2231-5691.2020.00008.8.
Pingale R, Pokharkar D, Phadatare SP, Gorle A. Pharmacognostic evaluation of parkia biglandulosa bark. Int J Pharmacogn Phytochem Res. 2016;8(7):1160-3.
Saleh MSM, Jalil J, Zainalabidin S, Asmadi AY, Mustafa NH, Kamisah Y. Genus Parkia: phytochemical, medicinal uses, and pharmacological properties. Int J Mol Sci. 2021;22(2):618. doi: 10.3390/ijms22020618, PMID 33435507.
Mohanty S, Cock IE. Bioactivity of syzygium jambos methanolic extracts: antibacterial activity and toxicity. Pharmacognosy Res. 2010;2(1):4-9. doi: 10.4103/0974-8490.60577, PMID 21808530.
Dhanabalan R, Palaniswamy M, Devakumar J. Total polyphenol and flavonoid content of Syzygium jambos (L.) Alston leaf extracts and its in vitro DPPH radical scavenging activity. J Pharm Res. 2014;8(4):593-6.
Begum M, Haque M, Ferdous R, Hasan M, Tarek H, Alam N. Screening of antioxidant and antimicrobial properties of the Syzygium jambos L. American journal of bio science. Pharmacol Phytochemicals Investig. 2015;3(2-1):23-6.
Anonymous. Indian pharmacopoeia. 6th ed. Vol. 1. Government of India, Ministry of Health and family Welfare; 2010. p. A-185.
Lechmann L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy tablets. 4th ed. Bombay: Varghese Publishing House; 1991. p. 293-345.
ICH harmonised tripartite guideline. Stab Test New Drug Subst Prod. Q1A (R2). Geneva: International Conference of Harmonization; 2009.
Published
How to Cite
Issue
Section
Copyright (c) 2023 ROHINI C. KOLHE, RAJESH Y. CHAUDHARI
This work is licensed under a Creative Commons Attribution 4.0 International License.